Clinical Characteristics of Lipid Metabolism in Untreated Patients with Anti-MDA5 Antibody-Positive

References

• Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52(5):1571–1576. doi:10.1002/art.21023
   PubMed Web of Science ®Google Scholar
• Sato S, Hoshino K, Satoh T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009;60(7):2193–2200. doi:10.1002/art.24621
   PubMed Web of Science ®Google Scholar
• Muro Y, Sugiura K, Akiyama M. Cutaneous manifestations in dermatomyositis: key clinical and serological features-a comprehensive review. Clin Rev Allergy Immunol. 2016;51(3):293‐302. doi:10.1007/s12016-015-8496-5
   PubMed Web of Science ®Google Scholar
• Huang W, Tang L. Extensive subcutaneous calcification: a rare manifestation of dermatomyositis. Rheumatology. 2019;58(6):974. doi:10.1093/rheumatology/key395
   PubMed Web of Science ®Google Scholar
• Abe Y, Kusaoi M, Tada K, Yamaji K, Tamura N. Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy. Rheumatology. 2020;59(4):767‐771. doi:10.1093/rheumatology/kez357
   Web of Science ®Google Scholar
• Motegi SI, Sekiguchi A, Toki S, et al. Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease. Eur J Dermatol. 2019;29(5):511–517. doi:10.1684/ejd.2019.3634
   PubMed Web of Science ®Google Scholar
• Shirakashi M, Nakashima R, Tsuji H, et al. Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment. Rheumatology. 2020;59(11):3284–3292. doi:10.1093/rheumatology/keaa123
   PubMed Web of Science ®Google Scholar
• Yashiro M, Asano T, Sato S, et al. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum. Fukushima J Med Sci. 2018;64(2):89–94. doi:10.5387/fms.2018-01
   PubMed Web of Science ®Google Scholar
• Huang K, Vinik O, Shojania K, et al. Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review. Rheumatol Int. 2019;39(11):1971–1981. doi:10.1007/s00296-019-04398-2
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang K, Yang L, et al. Lipid metabolism in inflammation-related diseases. Analyst. 2018;143(19):4526–4536. doi:10.1039/C8AN01046C
   PubMed Web of Science ®Google Scholar
• Raouf J, Idborg H, Englund P, et al. Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis. Arthritis Res Ther. 2018;20(1):83. doi:10.1186/s13075-018-1579-y
   PubMed Web of Science ®Google Scholar
• Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European league against rheumatism/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955–1964. doi:10.1136/annrheumdis-2017-211468
   PubMed Web of Science ®Google Scholar
• Ryu H, Kim J, Kim D, Lee JE, Chung Y. Cellular and molecular links between autoimmunity and lipid metabolism. Mol Cells. 2019;42(11):747–754. doi:10.14348/molcells.2019.0196
   PubMed Web of Science ®Google Scholar
• Pinkas J, Bojar I, Gujski M, Bartosińska J, Owoc A, Raczkiewicz D. Serum lipid, vitamin D levels, and obesity in perimenopausal and postmenopausal women in non-manual employment. Med Sci Monit. 2017;23:5018–5026. doi:10.12659/MSM.906895
   PubMed Web of Science ®Google Scholar
• Wang X, Ding X, Su S, et al. Heritability of insulin sensitivity and lipid profile depend on BMI: evidence for gene-obesity interaction. Diabetologia. 2009;52(12):2578–2584. doi:10.1007/s00125-009-1524-3
   PubMed Web of Science ®Google Scholar
• Huang W, Ren F, Wang Q, et al. Clinical features of thirty-two patients with anti-melanoma differentiation-associated gene 5 antibodies. Clin Exp Rheumatol. 2019;37(5):803–807.
   PubMed Web of Science ®Google Scholar
• Bauhammer J, Blank N, Max R, et al. Rituximab in the treatment of Jo1 antibody-associated antisynthetase syndrome: anti-Ro52 positivity as a marker for severity and treatment response. J Rheumatol. 2016;43(8):1566–1574. doi:10.3899/jrheum.150844
   PubMed Web of Science ®Google Scholar
• Kozu KT, Silva CA, Bonfá E, et al. Dyslipidaemia in juvenile dermatomyositis: the role of disease activity. Clin Exp Rheumatol. 2013;31(4):638–644.
   PubMed Web of Science ®Google Scholar
• Krawczyk SA, Haller JF, Ferrante T, Zoeller RA, Corkey BE, Rishi A. Reactive oxygen species facilitate translocation of hormone sensitive lipase to the lipid droplet during lipolysis in human differentiated adipocytes. PLoS One. 2012;7(4):e34904. doi:10.1371/journal.pone.0034904
   PubMed Web of Science ®Google Scholar
• Jarc E, Petan T. Lipid droplets and the management of cellular stress. Yale J Biol Med. 2019;92(3):435–452.
   PubMed Web of Science ®Google Scholar
• Sadanand S, Paul BJ, Thachil EJ, Meletath R. Dyslipidemia and its relationship with antiphospholipid antibodies in APS patients in North Kerala. Eur J Rheumatol. 2017;3(4):161–164. doi:10.5152/eurjrheum.2016.16041
   Google Scholar
• Aktas G, Kocak MZ, Bilgin S, Atak BM, Duman TT, Kurtkulagi O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23(5):1098–1102. doi:10.1080/13685538.2019.1678126
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Duman TT, Atak BM, Savli H. Is Uric Acid elevation a random finding or a causative agent of diabetic nephropathy? Rev Assoc Med Bras. 2019;65(9):1155–1160. doi:10.1590/1806-9282.65.9.1156
   PubMed Web of Science ®Google Scholar
• Norata GD, Pirillo A, Ammirati E, Catapano AL. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis. 2012;220(1):11–21. doi:10.1016/j.atherosclerosis.2011.06.045
   PubMed Web of Science ®Google Scholar
• Mendez AJ, Lin G, Wade DP, Lawn RM, Oram JF. Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J Biol Chem. 2001;276(5):3158–3166. doi:10.1074/jbc.M007717200
   PubMed Web of Science ®Google Scholar
• Krause BR, Remaley AT. Reconstituted HDL for the acute treatment of acute coronary syndrome. Curr Opin Lipidol. 2013;24(6):480–486. doi:10.1097/MOL.0000000000000020
   PubMed Web of Science ®Google Scholar
• Barlage S, Gnewuch C, Liebisch G, et al. Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation. Intensive Care Med. 2009;35(11):1877–1885. doi:10.1007/s00134-009-1609-y
   PubMed Web of Science ®Google Scholar
• Gono T, Sato S, Kawaguchi Y, et al. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology. 2012;51(9):1563–1570. doi:10.1093/rheumatology/kes102
   PubMed Web of Science ®Google Scholar